888.552.6760 SCHEDULE A CONSULTATION

Discussing ICIs in Endometrial Cancer for Cancer Immunotherapy Month

June 29, 2021

Dr. Maurie Markman, Cancer Treatment Centers of America® (CTCA) President of Medicine & Science, addresses different treatment options, including checkpoint inhibitors, for patients with endometrial cancer in an interview with Targeted Oncology™ for Cancer Immunotherapy Month.

Read more here

About Cancer Treatment Centers of America
Cancer Treatment Centers of America® (CTCA) is a national oncology network of hospitals and outpatient care centers offering an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA® publishes treatment results bi-annually including patient experience, length of life, quality of life, patient safety and quality of care. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com for more information.